Здравоохранение: текущие обзоры

Краткое сообщение

Monitoring hypoglycemia and glycaemic variability through CGM devices in type 2 diabetes patients

• Sudhanshu Mishra

Краткое сообщение

Metabolic clustering of risk factors: Evaluation of triglyceride-glucose index (TyG index) for evaluation of insulin resistance

• Sikandar Hayat Khan

Краткое сообщение

Cardiovascular aspects of the patients with diabetes

• Maryna Dolzhenko

Краткое сообщение

Would it be advantageous utilizing beta cell therapies over immunotherapies for avoidance of type 1 diabetes - A systematic Review on the role of beta cells in etiopathogenesis of type 1 diabetes along with treatments targeting beta cells or combination therapy would be better

• Kulvinder Kochar Kaur

Краткое сообщение

Diabetic kidney disease: Where are we and what does the future hold

• George Bakris

Краткое сообщение

Comparison of adverse effects among different GLP-1 receptor agonists added to basal insulin and between GLP-1 receptor agonists and basal Insulin versus basal-plus or basal-bolus insulin in type 2 diabetes

• Andrey Emanuilov Manov*, Ashan Thomas Hatharasinghe and Katrina Equinox Lopez